Hostname: page-component-6766d58669-kn6lq Total loading time: 0 Render date: 2026-05-18T04:15:57.159Z Has data issue: false hasContentIssue false

Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia

Published online by Cambridge University Press:  29 June 2007

Valerie J. Lund*
Affiliation:
Institute of Laryngology and Otology, 330 Grays Inn Rd, London, UK.
David J. Howard
Affiliation:
Institute of Laryngology and Otology, 330 Grays Inn Rd, London, UK.
*
Address for correspondence: Professor V.J. Lund, M.S., F.R.C.S., Professorial Unit, Royal National Throat Nose and Ear Hospital, 330/332 Gray's Inn Road, London WC1X 8DA.

Abstract

From a cohort of 35 patients with hereditary haemorrhagic telangiectasia (HHT), 12 patients have undergone closure of the one or both nasal cavities during the last three years for refractory epistaxis. All had failed other forms of treatment including hormone therapy, laser coagulation and septodermoplasty. All patients were available for follow-up at six months or longer. In all patients where complete closure was achieved (11 out of 12) bleeding ceased completely from the operated side.

Information

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable